Filer Snapshot

Steven Weber

CIK 0001844594. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

17

Latest filing

16 Jul 2025

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for IGMS. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 16 Jul 2025 for CIK 0001844594.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

Forms 3/4/5 positions$31.8K

Reporting-owner positions with enough filing detail to estimate value.

Forms 3/4/5 position value

3/4/5
$31.8K

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Source: Forms 3/4/5Confidence: Estimated when price data is available

Largest linked holdings

Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.

IGMS
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
C/O Aeglea Biotherapeutics, Inc., 805 Las Cimas Parkway, Suite 100, Austin, TX, 78746

Filer intelligence

What SEC filings say about Steven Weber

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for IGMS worth $31.8K.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 3 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

IGMS

16 Jun 2025 · PRINCIPAL ACCOUNTING OFFICER

$31.8K

PLSE

14 Jul 2025 · Principal Accounting Officer

AGLE

17 Feb 2022 · VP, Controller&Princ Acctg Off

Latest update

What changed recently for Steven Weber

Ownership report updated

Latest ownership report period: 14 Jul 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

16 Jul 2025

Page type

Ownership filings

Latest period

14 Jul 2025

Ownership context was refreshed from SEC Forms 3/4/5 filed on 16 Jul 2025.

SEC filing record

CIK 0001844594 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
17
First seen
08 Feb 2021
Latest filing
16 Jul 2025
Entity
Individual

Observed form types

4 3

Latest Filings

Showing the latest 12 of 17 SEC filings for Steven Weber.

4 File 001-37744

FORM 4

Filing date
16 Jul 2025
Reporting date
14 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-37744

FORM 3

Filing date
16 Jul 2025
Reporting date
14 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39045

4 filing

Filing date
20 Jun 2025
Reporting date
16 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39045

4 filing

Filing date
16 May 2025
Reporting date
14 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39045

4 filing

Filing date
18 Mar 2025
Reporting date
14 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39045

4 filing

Filing date
17 Jan 2025
Reporting date
15 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39045

4 filing

Filing date
18 Dec 2024
Reporting date
16 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39045

4 filing

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39045

4 filing

Filing date
17 Sep 2024
Reporting date
13 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39045

4 filing

Filing date
18 Jun 2024
Reporting date
14 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39045

4 filing

Filing date
15 Mar 2024
Reporting date
13 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39045

4 filing

Filing date
14 Mar 2024
Reporting date
12 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .